Tag: Unresponsive

Samantha Keow, BSc Credit: LinkedIn Abrocitinib serves as an efficacious therapy for individuals with moderate-to-severe atopic dermatitis (MtS-AD) who either fail to respond to, are unable to tolerate, or report adverse events (AEs) with biologic treatments, according to new findings.1 These results were the conclusion of new research led by Samantha Keow, BSc, from the […]